News Bio-Techne Corporation

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-07 pm EDT			5-day change	1st Jan Change
77.46 ^USD	+1.84%		+22.54%	+0.39%

May. 06	Argus Adjusts Price Target on Bio-Techne to $95 From $90, Keeps Buy Rating	MT
May. 02	UBS Adjusts Price Target on Bio-Techne to $90 From $80, Maintains Buy Rating	MT

Argus Adjusts Price Target on Bio-Techne to $95 From $90, Keeps Buy Rating	May. 06	MT
UBS Adjusts Price Target on Bio-Techne to $90 From $80, Maintains Buy Rating	May. 02	MT
Leerink Partners Adjusts Price Target on Bio-Techne to $95 From $85	May. 02	MT
Scotiabank Adjusts Price Target on Bio-Techne to $83 From $80	May. 02	MT
RBC Capital Adjusts Price Target on Bio-Techne to $72 From $71, Sector Perform Rating Kept	May. 02	MT
Baird Adjusts Bio-Techne Price Target to $81 From $73	May. 02	MT
Equity Markets Mostly Fall After Fed Leaves Rate Unchanged	May. 01	MT
Equity Markets Mostly Fall After Fed Leaves Rate Unchanged	May. 01	MT
Top Midday Gainers	May. 01	MT
US Equity Indexes Mixed as Investors Look for Clarity in Fed's Policy Path in Presidential Election Year	May. 01	MT
US Equity Indexes Mixed Ahead of Fed Policy Statement, Views on Monetary Policy Path for 2024	May. 01	MT
Bio-Techne Shares Jump After Fiscal Q3 Beat	May. 01	MT
Deutsche Bank Adjusts Price Target on Bio-Techne to $84 From $82	May. 01	MT
Transcript : Bio-Techne Corporation, Q3 2024 Earnings Call, May 01, 2024	May. 01
Bio-Techne's Fiscal Q3 Adjusted Earnings Fall, Net Sales Rise	May. 01	MT
Earnings Flash (TECH) BIO-TECHNE CORPORATION Reports Q3 Revenue $303.4M	May. 01	MT
BIO-TECHNE DECLARES DIVIDEND	May. 01	PR
BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS	May. 01	PR
Bio-Techne Corporation Declares Dividend for the Quarter Ended March 31, 2024, Payable on May 24, 2024	May. 01	CI
BIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS	Apr. 30	PR

No results for this search